EmilyStamell(Stamell)RuizMD

Physician

Dr. Ruiz is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Montefiore Medical Center/Albert Einstein College of MedicineResidency, Dermatology, 2011 - 2014
NYU Grossman School of MedicineInternship, Internal Medicine, 2010 - 2011
New York University School of MedicineClass of 2010

PubMed

Combined topical 5-fluorouracil and calcipotriene effectively treats superficial keratinocyte carcinomas: A retrospective cohort study from 2 academic centers.
Nicole Loranger, Fatima N Mirza, Truelian Lee, Ethan Lowder, Emily Karn
Journal of the American Academy of Dermatology. 2024-11-10
Most cutaneous squamous cell carcinoma recurrences occur in the first 3 years after diagnosis: A multicenter retrospective cohort study.
Emily E Granger, Nina A Ran, Morgan K Groover, Shlomo A Koyfman, Allison T Vidimos
Journal of the American Academy of Dermatology. 2024-11-01
Cutaneous Squamous Cell Carcinoma in Transketolase Deficiency.
Nicole Loranger, Anastasia Vishnevetsky, Michele Spencer-Manzon, Emily Karn, Wendy K Chung
JAMA Otolaryngology-- Head & Neck Surgery. 2024-11-01

Lectures

High Yield ""Power Hour"" for Residents
American Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/2/2019
National cancer expenditure analysis in the United States Medicare population, 2013.
2019 ASCO Annual Meeting - 6/1/2019

FDA Approves Cosibelimab-Ipdl for Advanced Cutaneous Squamous Cell CarcinomaDecember 17th, 2024
Castle Biosciences Presents New Data at ASDS from Prospective, Multicenter CONNECTION Study Supporting Use of DecisionDx®-Melanoma to Guide SLNB Decisions in T1a Tumors with High-Risk Features and T1b TumorsOctober 20th, 2024
Study Confirms the Ability of Castle Biosciences’ DecisionDx®-SCC Test to Predict Likelihood of Benefit from Adjuvant Radiation Therapy in Patients with High-Risk Cutaneous Squamous Cell CarcinomaSeptember 5th, 2024
Join now to see all